Ecolab (ECL)
Delivers industrial water-treatment, hygiene, purification, and pest-control programs through a direct service network.
Something off on this page? Send us feedback.
Provides water-treatment and process chemistry, institutional cleaning and sanitation, biopharma contamination-control and purification products, and commercial pest services. Revenue comes from consumables, equipment, digital tools, and recurring field service delivered through a large direct sales-and-service network at industrial and institutional sites worldwide.
Provides water treatment and process chemistry through Global Water; cleaning and sanitation through Global Institutional & Specialty; commercial pest management through Global Pest Elimination; and biopharma contamination control, decontamination, and purification through Global Life Sciences. Ovivo Electronics' ultrapure-water systems and CoolIT's direct liquid-cooling equipment extend the water portfolio into semiconductor fabrication and data centers.
Combines consumable chemistry with monitoring, dispensing and treatment equipment, digital tools, and a direct field-service network to manage water use, hygiene, product quality, and operating efficiency at customer sites. Operations span the world, with the United States the largest market and nearly half of sales generated elsewhere.
Depends on technical coverage at customer facilities, access to chemicals and equipment components, and product registrations governing pesticides, biocides, medical devices, drugs, and food-contact antimicrobials.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 29, 2026 | UBS | Reiterate | Rating: —Target: $325 | Target: $342 |
| Jul 29, 2026 | BMO Capital | Reiterate | Rating: —Target: $345 | Target: $360 |
| Jul 29, 2026 | Mizuho Securities | Target | Target: $335 | Target: $327 |
| Jul 29, 2026 | Robert W. Baird | Target | Target: $327 | Target: $305 |
| Jul 17, 2026 | Oppenheimer | Reiterate | Rating: —Target: — | Target: $320 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $5.14B · Total debt $13.75B · Total assets $29.93B · Shareholders' equity $10.06B
- Revenue
- $4.42B
- Operating income
- $757.9M
- Net income
- $534.9M
HistoryDividendAnnual yield
| Institutions | 81.28% | 227.86M shares | |
|---|---|---|---|
| 1,747 holders · as of Jun 30, 2026 | |||
| Insiders | 10.56% | 29.60M shares | |
| 31 holders · as of Sep 14, 2026 | |||
| Other | 8.16% | 22.87M shares | |
| remainder | |||
280.33M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
William H. Iii GatesInsider10 percent owner | 10.41% | 29.18M | filed Nov 22, 2024 |
BlackRock, Inc.Institution | 8.22% | 23.05M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 5.90% | 16.54M | as of Jun 30, 2026 |
JPMorgan Chase & CoInstitution | 5.22% | 14.62M | as of Jun 30, 2026 |
State Street CorpInstitution | 4.20% | 11.77M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 11, 2026 | Eric Mark Green | director | +3,690 | $276.64 |
| Aug 18, 2026 | Christophe Beck | director, officer: CHAIRMAN, PRESIDENT & CEO | −17,862 | $280.14 |
| Aug 11, 2026 | Gregory B. Cook | officer: Co-COO - Global Businesses | −4,567 | $285.13 |
| Jul 30, 2026 | Scott D. Kirkland | officer: CHIEF FINANCIAL OFFICER | −3,357 | $276.96 |
| Jun 11, 2026 | Benjamin M. Clark | officer: EVP - Global Supply Chain | +1,000 | $263.83 |
- Veralto
Danaher spin-off; ChemTreat and Hach contest Nalco Water in industrial treatment
- Rentokil Initial (ADR)
World's #1 pest control company; competes in commercial pest and hygiene
- Rollins
World's #2 pest control company; 10-K names Ecolab as a major competitor
- STERIS
Primary rival in biopharma contamination control and healthcare sterility
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ecolab | $275.45 | +2.03% | $75.98B | 36.2 | 31.9 | 4.5 | +9.7% |
| Veralto | $95.78 | +0.63% | $23.20B | 24.0 | 21.2 | 4.1 | +7.5% |
| Rentokil Initial (ADR) | $21.54 | +0.82% | $10.75B | 22.7 | — | 1.5 | −21.7% |
| Rollins | $32.68 | +1.02% | $15.57B | 29.4 | 27.2 | 4.0 | +7.9% |
| STERIS | $208.57 | +0.77% | $20.17B | 25.3 | 18.2 | 3.3 | +7.1% |
| Median | 24.7 | 21.2 | 3.7 | +7.3% |